Delivery Order SPE2DP20D0002-SPE2DP24F7168
Award Date
8/22/24
Potential Completion Date
8/27/24
Potential Value
$159K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 fixed-price delivery order is for the supply of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $64,352,514.80 IDC with the Department of Veterans...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm fixed-price delivery order (SPE2DP24F7177) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This order is part of a larger Indefinite Delivery Contract (SPE2DP20D0002) held by Teva to provide essential medications to federal agencies such as the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $476,414.19, is for the supply of Adenovirus Type 4 vaccine, a critical product that supports military immunization programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Teva and the Department of Veterans Affairs (VA) National Acquisition Center,...
The U.S. Defense Logistics Agency (DLA) awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $317,609.46 Delivery Order contract for the supply of Adenovirus Type 4 vaccines. This order falls under DLA Troop Support Medical's larger portfolio of contracts supporting military immunization programs. The contract has a firm fixed-price, with a completion date of June 25, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drugs and...
The Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order worth $458,090.64 to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This contract supports military immunization programs. Teva is an experienced federal contractor, having provided a variety of drug products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. This order has a completion date of January 30, 2024 and is not a set-aside contract. Teva Pharmaceuticals USA, Inc. provides critical pharmaceutical products to federal agencies like the Department of Veterans Affairs (VA), Department of Defense (DOD),...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $1,111,633.11 firm-fixed-price delivery order is for the supply of Adenovirus Type 4 vaccine, a critical product used in military immunization programs. This award falls under a larger $5.7 million Indefinite Delivery Contract (IDC) that establishes Teva as the national prime vendor to provide...
This federal contract award, valued at $158,804.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a large, foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 27, 2024. Teva Pharmaceuticals USA, Inc. has a long history of supplying...
This federal contract award, valued at $317,609.46, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc. for the delivery of the Adenovirus Type 4 vaccine. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that serves as a major supplier of critical drug products to various U.S. federal government agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $635,218.92 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This vaccine supports military immunization programs. The contract has a completion date of July 30, 2024 and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. serves as a major supplier of critical drug products to...